超临界流体发泡技术制备含PLLA缓释微球nHA/PLGA复合支架及体外释放性能研究
Release Performance in Vitro of nHA/PLGA Scaffolds Contained with Protein Sustained-Release PLLA Microspheres Prepared by Means of Supercritical Fluid Foaming Technology

作者: 李培培 , 白燕 , 尹光福 :四川大学材料科学与工程学院;

关键词: 聚乳酸–羟基乙酸聚乳酸载药微球组织工程支架超临界流体发泡技术Poly Lactic-Co-Glycolic Acid Poly-L-Lactic Acid Drug Loaded Microspheres Tissue Engineering Scaffolds Supercritical Fluid Foaming Technique

摘要:
本研究以胰蛋白酶(Try)为模型蛋白,将蛋白缓释微球与可降解多孔支架相结合,构建在骨修复不同阶段可控释放不同生长因子的组织工程支架。首先制备胰蛋白酶-聚乳酸微球(Try-PLLAmsms微球),然后复合到纳米羟基磷灰石/聚乳酸羟基乙酸(nHA/PLGA)中,通过超临界流体发泡制备含蛋白缓释微球的多孔支架。结果表明,制备的Try-PLLAms形态良好,呈规则球形,粒径集中分布在2~7 μm,蛋白包封率为80.5%,载药量为0.89%。制备的Try-PLLAms/nHA/PLGA复合支架孔径为150~300 μm,孔隙率为50.9%~76.8%,压缩强度3.9~5.1 MPa8周降解率为19.8%Try-nHA/PLGA支架及Try-PLLAms微球48小时Try累积释放量达分别为85%65.2%,而复合支架Try 48小时累积释放量为32.9%21天累积释放量为60.6%Try-PLLAms/nHA/PLGA复合支架的抗压强度和释放规律合适,对蛋白类药物具有良好的缓释作用,有望作为具有蛋白类药物缓释功能的组织工程支架。

Abstract:
In order to construct a bone regeneration system that different cell factors controlled release at proper stage, Trypsin (Try) was selected as the model protein, and the composite of sustained-release microspheres and biodegradable porous scaffolds was prepared in this study. First of all, Try loaded poly-l-lactic acid microspheres (Try-PLLAms) were prepared, and then compounded to the nano hydroxyapatite/poly lactic-co-glycolic acid (nHA/PLGA) to build a scaffold that can release growth factors sequentially. The results showed that the Try-PLLAms were spherical shape with diameters of 2 - 7 μm. The encapsulation efficiency of the Try in PLLAms was 80.5%, and the loading capacity was 0.89%. The prepared Try-PLLAms/nHA/PLGA scaffold possessed 150 - 300 μm pore diameter, 50.9% - 76.8% porosity, 3.9 - 5.1 MPa compressive strength, and 19.8% degradation at 8 weeks. The cumulative releases of Try from Try- nHA/PLGA scaffolds and from Try-PLLAms were respectively about 85% and 65.2% at 48 hours, and that from Try-PLLAms/nHA/ PLGA scaffolds were 32.9% at 48 hours and 60.6% at 21 days. The results demonstrated that Try-PLLAms/nHA/PLGA scaffolds had excellent drug release performance with suitable compressive strength, which would be used as tissue engineering scaffolds with protein delivery.

文章引用: 李培培 , 白燕 , 尹光福 (2013) 超临界流体发泡技术制备含PLLA缓释微球nHA/PLGA复合支架及体外释放性能研究。 材料科学, 3, 110-115. doi: 10.12677/MS.2013.33021

参考文献

[1] X. F. Niu, Q. L. Feng, M. B. Wang, X. D. Guo and Q. X. Zheng. In vitro degradation and release behavior of porous poly(lactic acid) scaffolds containing chitosan microspheres as a carrier for BMP-2-derived synthetic peptide. Polymer Degradation and Stability, 2009, 94(2): 176-182.

[2] Paul T. Thevenot, A. M. Nair, J. H. Shen, P. Lotfi, C.-Y. Ko and L. P. Tang. The effect of incorporation of SDF-1α into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials, 2010, 31(14): 3997-4008.

[3] A. M. Ambrosio, J. S. Sahota and Y. Khan. A novel amorphous calcium phosphate polymer ceramic for bone repair: I. Synthesis and characterization. Journal of Biomedical Materials Research, 2001, 58(3): 295-301.

[4] 赵君, 蒋欣泉, 张志愿. 羟磷灰石/聚乙丙交酯生物复合材料的研究进展[J]. 国际口腔医学杂志, 2008, 35(2): 207-209.

[5] F. Deschaseaux, L. Sensébé and D. Heymann. Mechanisms of bone repair and regeneration. Trends in Molecular Medicine, 2009, 15(9): 417-429.

[6] J. Glowack. Angiogenesis in fracture repair. Clinical Orthopaedics and Related Research, 1998, 335: S82-S89.

[7] H. P. Gerber, N. Ferrara. Angiogenesis and bone growth. Trends in Cardiovascular Medicine, 2000, 10(5): 223-228.

[8] J. Schmid, B. Wallkamm, C. H. Hammerle, S. Gogolewski and N. P. Lang. The significance of angiogenesis in guided bone regeneration. A case report of a rabbit experiment. Clinical Oral Implants Research, 1997, 8(3): 244-248.

[9] H. Winet. The role of microvasculature in normal and perturbed bone healing as revealed by intravital microscopy. Bone, 1996, 19(1): S39-S57.

[10] H. Winet, J. Y. Bao and R. Moffat. A control model for tibial cortex neovascularization in the bone chamber. Journal of Bone and Mineral Research, 1990, 5(1): 19 -30.

[11] K. Sojo, Y. Sawaki, H. Hattori, H. Mizutani and M. Ueda. Immunohi stochemical study of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2, -4 (BMP-2, -4) on lengthened rat femurs. Journal of Cranio-Maxillofacial Surgery, 2005, 33(4): 238-245.

[12] L. D. Harris, B.-S. Kim and D. J. Mooney. Open pore biodegradable matrices formed with gas foaming. Journal of Biomedical Materials Research, 1998, 42(3): 396-402.

[13] W. L. Murphy, M. C. Peters, D. H. Kohn and D. J. Mooney. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials, 2000, 21(24): 2521-2527.

[14] M. H. Sheridan, L. D. Shea, M. C. Peters and D. J. Mooney. Bioadsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. Journal of Controlled Release, 2000, 64(1-3): 91-102.

[15] T. P. Richardson, M. C. Peters, A. B. Ennett and D. J. Mooney. Polymeric system for dual growth factor delivery. Nature Biotechnologyl, 2001, 19: 1029-1034.

[16] D. J. Mooney, D. F. Baldwin, N. P. Suh, L. P. Vacanti and R. Langer. Novel approach to fabricate porous sponges of poly(D,L- lactic-co-glycolic acid) without the use of organic solvents. Biomaterials, 1996, 17(14): 1417-1422.

[17] S. K. Goel, E. J. Beckman. Generation of microcellular polymeric foams using supercritical carbon dioxide. I. Effect of pressure and temperature on nucleation. Polymer Engineering & Science, 1994, 34(14): 1137-1147.

[18] H. Tai, M. Mather, D. Howard, W. Wang, L. White and J. Crowe. Control of pore size and structure of tissue engineering scaffolds produced by supercritical fluid processing. European Cells and Materials, 2007, 14: 64-77.

[19] C. Gualandi, L. J. White, L. Chen, R. A. Gross, K. M. Shake- sheff and S. M. Howdle. Scaffold for tissue engineering fabricated by non-isothermal supercritical carbon dioxide foaming of a highly crystalline polyester. Acta Biomaterialia, 2010, 6(1): 130-136.

[20] C. J. Liao, C. F. Chen and J. H. Chen. Fabrication of porous biodegradable polymer scaffolds using a solvent merging/par- ticulate leaching method. Journal of Biomedical Materials Research, 2002, 59(4): 676-681.

[21] S. S. Kim, S. J. Gwak and B. S. Kim. Orthotropic bone formation by implantation of apatite-coated poly (lactide-co-glycolide)/ hydroxyapatite composite particulates and bone morphogenetic protein-2. Journal of Biomedical Materials Research, 2008, 87A(1): 245-253.

分享
Top